SAN FRANCISCO, Aug. 5 /PRNewswire-FirstCall/ -- Merriman Curhan Ford (Nasdaq: MERR) actedas sell-side financial advisor to Outcome Concept Systems, Inc. (OCS) in its sale to National Research Corporation (Nasdaq: NRCI). National Research Corporation acquired the outstanding shares of OCS in an all cash transaction. Following the acquisition,
Details on the transaction can be found at National Research Corporation's Web site: http://www.nationalresearch.com/
About Outcome Concept Systems, Inc.
Founded in 1992 and based in Seattle, Washington, Outcome Concept Systems, Inc. (OCS) is a privately-held leading healthcare analytics provider serving the homecare industry. OCS partners with over 3,000 homecare and hospice providers throughout the United States. The company houses the nation's largest warehouse of homecare outcomes, quality, financial and satisfaction metrics. The Company delivers a range of innovative offerings for providers, vendors, investors and consultants.
About National Research Corporation
National Research Corporation (NASDAQ: NRCI) is a healthcare research and quality improvement firm offering performance measurement and improvement services to health plans, hospitals, health care systems, physicians, and other healthcare organizations. Dedicated solely to the healthcare industry, NRC is a leading provider of ongoing performance measurement, improvement, analysis and tracking services to healthcare organizations. NRC is a technical innovator, with state-of-the-art systems for large scale research projects and cutting edge web-based tools for improving service quality.
About Merriman Curhan Ford
Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in growth industry sectors: Technology, CleanTech and Consumer, Media & Internet. For more information, please go to www.mcfco.com.
Note to Investors
This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of the Company. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K/A filed on April 30, 2010. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-K/A filed on April 30, 2010 and the Form 10-Q filed on May 17, 2010, together with this press release and the financial information contained herein, are available on our website, www.mcfco.com. Please click on "Investor Relations."
SOURCE Merriman Curhan Ford
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All